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Purpose: To describe the clinical features of and identify a novel mutation in Bardet–Biedl syndrome 7 gene (BBS7) in
a Chinese family.
Methods: Nineteen individuals at risk for inheriting Bardet-Biedl syndrome (BBS) in a Chinese family participated in
the study. Physical examination was performed and blood was drawn for DNA extraction. Linkage analysis was conducted
for all known BBS loci, and mutation screening of BBS7 gene and BBS12 gene was performed.
Results: A Chinese family with inherited BBS was identified. After performing linkage analysis on all 13 known loci,
we found the disease phenotype of a Chinese family with BBS linked to a locus where BBS7 and BBS12 genes locate.
Conclusions: This study describes a novel mutation in BBS7 causing BBS in a Chinese family. This is the first report that
a mutation in a BBS gene causes BBS in a Chinese population. These results expand the spectrum of human disease
associated with mutations of BBS7 since the initial three mutations in BBS7 were first identified in 2003.
Bardet–Biedl  syndrome  (BBS;  OMIM  209900)  is  an
autosomal  recessive  disorder  characterized  by  pleiotropic
defects  including  obesity,  retinal  dystrophy,  polydactyly,
hypogenitalism, learning difficulties, and renal abnormalities
[1,2],  as  well  as  diseases  such  as  diabetes  mellitus,
hypertension,  and  congenital  heart  disease  [1,3,4].  The
disorder displays genetic heterogeneity. So far, fourteen genes
have been mapped and cloned: including BBS1 (11q13), BBS2
(16q21), BBS3 (3p12-q13), BBS4 (15q22.3), BBS5 (2q31),
BBS6 (20p12), BBS7 (4q27), BBS8 (14q32.11), BBS9 (7p14),
BBS10 (12q21.2), BBS11 (9q33.1), BBS12 (4q27), BBS13
(17q23), and BBS14 (12q21.3) [2,5-18]. There are still about
25%–50% of BBS families without any mutation in these
genes [10,19,20]. In vitro and in vivo studies of the known
BBS genes and their products have demonstrated that BBS is
a  disorder  of  defective  primary  ciliary  and  basal  body
function,  probably  affecting  both  transport  and  paracrine
signals such as the planar cell polarity pathway [2,10,12,21,
22]. A relatively high incidence of BBS is found in the mixed
Arab populations of Kuwait and in Bedouin tribes throughout
the  Middle  East,  most  likely  due  to  the  high  rate  of
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consanguinity in these populations and a founder effect. Three
mutations linked to BBS have been previously described in
BBS7 (T211I, K237fsX296, and H323R) [17]. However, no
BBS gene mutation has been reported in Chinese populations.
Here we report for the first time that a novel mutation in BBS7
gene causes BBS in a Chinese family.
METHODS
Study subjects: Approval from the Institutional Review Board
of the Sichuan Academy of Medical Sciences and Sichuan
Provincial People’s Hospital, China was obtained for this
study,  and  informed  consent  was  obtained  from  all
participants. The study enrolled 19 individuals from a Chinese
family  who  were  at  risk  for  inheriting  BBS.  Physical
examination was performed, and blood was drawn for DNA
extraction. Individuals with BBS were ascertained on the basis
of  criteria  established  elsewhere,  including  the  cardinal
features such as retinal dystrophy or other ocular abnormality,
obesity,  learning  difficulties,  polydactyly,  hypogenitalism
(males), renal abnormality, and other clinical features [1].
Measurements were made of height and weight. Photographs
were taken of the entire body including the hands, feet, and
specific dysmorphic features. Renal function was tested. The
eyes  were  examined  with  retinal-function  testing  (color-
vision  testing,  perimetry,  and  dark-adaption  testing)  and
electroretinographic studies, photography of the fundus, and
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2304fluorescein angiography. Urogenital system examination and
intelligence level evaluation were also conducted.
Genetic linkage and mutation screening: DNA was extracted
from blood samples, and genetic linkage was assessed using
short tandem repeat (STR) markers using established methods
[23,24]. The STR markers encompassing known BBS loci
including  BBS1  (D11S987,  D11S4191),  BBS2  (D16S415,
D16S503),  BBS3  (D3S3619,  D3S1752),  BBS4  (D15S131,
D15S205),  BBS5  (D2S2330,  D2S335),  BBS6  (D20S115,
D20S186), BBS7/BBS12 (D4S402, D4S427, GATA30B11),
BBS8 (D14S68, D14280), BBS9 (D7S516, D7S484), BBS10
(D12S376,  D12S326),  BBS11  (D9S1811,  GGAT11B01),
BBS13  (D17S787,  D17S944),  and  BBS14  (D12S326,
D12S351) were genotyped and analyzed. BBS7 and BBS12
mutation screening was performed by direct sequencing of
PCR-amplified  DNA  fragments  for  all  exons  using
established methods [24]. Amplified products were purified
using the QIAquik Gel Extraction Kit (Qiagen, Valencia, CA)
and  sequenced  with  forward  and  reverse  primers  by  the
BigDye®  Terminator  v3.1  Cycle  Sequencing  Kit  (ABI
Applied  Biosystems,  Foster  City,  CA)  according  to  the
manufacturers’ instructions.
RESULTS
Clinical findings: A Chinese consanguineous BBS family was
identified in southwest China. Of the 19 members at risk for
inheriting BBS in this family, five were diagnosed with BBS
(Figure 1). Two affected patients died of severe fever when
they were five years of age, and one affected patient died from
an accident. The two living affected patients displayed gross
obesity in relation to the average height of adult Chinese men.
In addition, these patients exhibited the following features:
atypical retinal dystrophy with attenuated vessels, choroidal
sclerosis-type  change,  severe  optic  disc  pallor  and  severe
macular dystrophy (Figure 2), obviously constricted visual
fields, severe abnormalities of color vision, reduced rod and
cone electroretinograph (ERG) response, refractive errors of
−10 (IV:2) and −8.0 (IV:4) diopters, polydactyly of hands and
feet,  hypogenitalism  (small  testes  and  genitalia),  learning
difficulties,  and  renal  abnormalities.  The  detailed  clinical
information for these two affected patients is listed in Table
1. Based on their symptoms, the affected patients were given
a diagnosis of BBS [1,2].
Genotyping and sequencing analysis: The genotyping results
showed that the BBS7/BBS12 encompassed STR markers,
D4S402,  D4S427,  and  GATA30B11,  completely
cosegregated with the phenotype in the family (Figure 1). But
no  linkage  was  found  to  any  other  known  BBS  loci.  No
mutation was found in BBS12. Mutation screening in the 19
exons of BBS7 found a 1666 A>G mutation in exon 15, which
resulted in an amino acid substitution from serine to arginine
at position 556 (Figure 3). This mutation was absent in 100
normal matched controls.
DISCUSSION
It  is  clear  that  BBS  is  a  pleiotropic,  autosomal  recessive
disorder. The cardinal phenotype in this family was identical
to most cases described previously [1,2] except that the ocular
phenotype of this family showed macular dystrophy instead
of a typical retinitis pigmentosa in BBS, further indicating the
variant retinal dystrophy in different BBS families. The ocular
manifestations of BBS included an early and usually severe
rod-cone dystrophy that is detected by ERG and causes central
and peripheral visual loss by the second to third decades of
life. More than 70% of the affected individuals are legally
blind by this time. High myopia associated with choroidal
sclerosis-type changes in our family further confirmed the
association of a myopia refractive error trend with BBS [19,
25].
To date, 13 loci and 14 genes have been mapped and
identified since the first BBS gene, MKKS, was identified in
2000 [2,18,25]. CCDC28B modifies the expression of BBS
phenotypes in the patients who have mutations in other genes
[2]. Mutations in BBS1 constitute the most mutations in the
known  BBS  families  (about  23%).  Mutations  in
BBS10,BBS2, and BBS12 account for 10%, 8%, and 5% of all
mutations, respectively. Other known BBS genes are rarely
Figure 1. Kindred structure and segregation of the STR markers in
the  family.  Genotyping  results  for  short  tandem  repeat  (STR)
markers,  D4S402,  D4S427,  GATA30B11,  which  tightly
encompassed BBS7, are shown below each individual. The disease
alleles of the STR markers and the mutation of BBS7 are completely
co-segregated with the phenotype of family. Affected individuals are
identified by solid squares (males) or solid circles (females). Normal
individuals are identified by open symbols; carry individuals are
identified by open symbols with a dot inside; deceased individuals
are indicated by a slash(/). Arrow indicates the proband of the family.
M, mutant allele of BBS7; +, normal allele of BBS7.
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2305mutated in the known BBS families [10,19]. The mutations in
these 14 genes probably affect both transport and paracrine
signals, such as the planar cell polarity pathway, and cause the
pleiotropic defects in affected BBS patients [2,10,12,16,18,
20-22,26].
In 2003, Badano, et al. [17] performed phylogenetic and
genomic studies in which they used the human and zebrafish
BBS2 peptide sequences to search dbEST and the translation
of the draft human genome. They identified a novel gene,
BBS2L1. BBS2L1 mutations cause BBS, defining a novel gene
for  this  syndrome,  BBS7.  BBS1,BBS2,  and  BBS7  share  a
distinct  substructure,  and  they  may  belong  to  a  distinct
subfamily of proteins [2,17]. Two transcript variants encoding
distinct isoforms have been identified for this gene. The length
of isoform 1 is 43 amino acids longer than that of isoform 2.
Isoform 2 is ubiquitously expressed, whereas isoform 1 is
expressed in retina, lung, liver, testis, ovary, prostate, small
intestine, liver, brain, heart, and pancreas. BBS7 may play a
role  in  eye,  limb,  cardiac,  and  reproductive  system
development. Blacque et al. [21] showed that mutations in the
Caenorhabditis  elegans  bbs-7  and  bbs-8  genes  cause
structural  and  functional  defects  in  cilia.  They  further
demonstrated that BBS7 and BBS8 are required for the normal
Figure 2. The retinal changes of the affected patients of the family.
Retinal dystrophy is one of main clinical features of Bardet–Biedl
syndrome (BBS). Fundus pictures (top left: OD; top right: OS) and
an angiography picture (bottom right: OS) of IV: 2 of the family
showed atypical retinal dystrophy with attenuated vessels, choroidal
sclerosis-type change, severe optic disc pallor, and severe macular
dystrophy. The fundus changes of the patient are different from the
typical retinal dystrophy of retinitis pigmentosa (RP) in BBS.
localization and motility of the intraflagellar transport (IFT)
proteins so the BBS7 protein plays an important role in the
assembly as well as function of IFT particle components.
These  findings  indicate  that  the  cardinal  and  secondary
symptoms  of  BBS  may  result  from  cilia  [21].  How  the
mutation in our family caused BBS is not understood as this
mutation is located closer to the C-terminal of BBS7 compared
with the three mutations reported previously. The initially
TABLE 1. CLINICAL FEATURES OF THE TWO AFFECTED PATIENTS.
Phenotype IV:2 IV:4
Gender Male Male
Current age (Y) 37 32
Retinal dystrophy Yes Yes
Ptosis Yes Yes
Strabismus Yes Yes
Obesity (BMI) Yes (25.6) Yes (25.2)
Developmental delay Severe Severe
Hypogenitalism Yes Yes
Learning/comprehension Delayed Delayed
Speech development Delayed Delayed
Memory Poor Poor
Motor skills Delayed Delayed
Hypotonia Yes Yes
Dental architecture Normal Normal
Tongue morphology Enlarged Enlarged
Voice Raspy Raspy
Behavior Labile Labile
Polydactyly Yes Yes
Renal abnormality Yes Yes
Eye movement Restrict Restrict
Diabetes No No
The two affected patients showed cardinal features of Bardet–
Biedl  syndrome (BBS) such as retinal dystrophy or other
ocular abnormality, obesity, learning difficulties, polydactyly,
hypogenitalism, renal abnormality, and other clinical features
of BBS.
Figure 3. Automated sequencing traces of the patients in the family.
The affected patient had an A>C transition in exon 15 of BBS7 in the
family.  The  carrier  showed  1666  A>C  heterozygous  mutation
(S556R), and the affected patient showed homozygous 1666 A>C
mutation (S556R) compared with the normal individual in the family.
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2306identified  three  mutations  are  located  in  a  predicted  β-
propeller region of BBS7 that is conserved between BBS2 and
BBS7. These findings may indicate that the β-propeller region
of BBS7 and the region involving the mutation identified in
this study play a critical role in the IFT system. The mutations
in these regions probably disturb the localization and motility
of the IFT proteins [17,21].
BBS is a rare development disorder, and 14 genes that
cause BBS have been identified. However, because of the
significant clinical and genetic heterogeneity of BBS, there
are still unknown genes involving at least 25%–50% of BBS
families  [10,15,16,27].  Studies  done  in  more  families,
especially from different ethnic populations, will be useful to
help identify other BBS disease-causing genes and mutations
and  to  better  understand  the  disease  mechanism  of  BBS.
Because  no  BBS  mutation  has  been  identified  in  a  large
Chinese population, the novel BBS7 mutation reported here
will expand the insight into our understanding of BBS.
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